ALLIQUA BIOMEDICAL INC - COM NEW (ALQA)

CUSIP: 019621200

Q3 2017 13F Holders as of 30 Sep 2017

Type / Class
Equity / COM NEW
Total 13F shares
4,557,428
Share change
-1,596,163
Total reported value
$1,675,000
Price per share
$0.37
Number of holders
20
Value change
-$594,218
Number of buys
8
Number of sells
10

Quarterly Holders Quick Answers

What is CUSIP 019621200?
CUSIP 019621200 identifies ALQA - ALLIQUA BIOMEDICAL INC - COM NEW in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of ALLIQUA BIOMEDICAL INC - COM NEW (ALQA) as of Q3 2017

As of 30 Sep 2017, ALLIQUA BIOMEDICAL INC - COM NEW (ALQA) was held by 20 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 4,557,428 shares. The largest 10 holders included Tekla Capital Management LLC, RENAISSANCE TECHNOLOGIES LLC, VANGUARD GROUP INC, J. Goldman & Co LP, Virtu Financial LLC, AMERIPRISE FINANCIAL INC, US BANCORP \DE\, Janney Montgomery Scott LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, and TWO SIGMA SECURITIES, LLC. This page lists 20 institutional shareholders reporting positions in this security for the Q3 2017 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.